Increasing cholesterol synthesis in 7-dehydrosterol reductase (DHCR7) deficient mouse models through gene transfer.
Smith-Lemli-Opitz syndrome (SLOS) is caused by deficiency in the terminal step of cholesterol biosynthesis: the conversion of 7-dehydrocholesterol (7DHC) to cholesterol (C), catalyzed by 7-dehydrocholesterol reductase (DHCR7). This disorder exhibits several phenotypic traits including dysmorphia and mental retardation with a broad range of severity. There are few proven treatment options. That most commonly used is a high cholesterol diet that seems to enhance the quality of life and improve behavioral characteristics of patients, although these positive effects are controversial. The goal of our study was to investigate the possibility of restoring DHCR7 activity by gene transfer. We constructed an adeno-associated virus (AAV) vector containing the DHCR7 gene. After we infused this vector into affected mice, the introduced DHCR7 gene could be identified in liver, mRNA was expressed and a functional enzyme was produced. Evidence of functionality came from the ability to partially normalize the serum ratio of 7DHC/C in treated animals, apparently by increasing cholesterol production with concomitant decrease in 7DHC precursor. By 5 weeks after treatment the mean ratio (for 7 animals) had fallen to 0.05 while the ratio for untreated littermate controls had risen to 0.14. This provides proof of principle that gene transfer can ameliorate the genetic defect causing SLOS and provides a new experimental tool for studying the pathogenesis of this disease. If effective in humans, it might also offer a possible alternative to exogenous cholesterol therapy. However, it would not offer a complete cure for the disorder as many of the negative implications of defective synthesis are already established during prenatal development.
Matabosch
Xavier
X
Children's Hospital Oakland Research Institute, 5700 Martin Luther King Jr Way, Oakland, CA 94609, United States.
Ying
Lee
L
Serra
Montserrat
M
Wassif
Christopher A
CA
Porter
Forbes D
FD
Shackleton
Cedric
C
Watson
Gordon
G
D000818:Animals; D002784:Cholesterol / Q000096:biosynthesis*; D000229:Dependovirus / Q000235:genetics; D004195:Disease Models, Animal; D018014:Gene Transfer Techniques; D005822:Genetic Vectors / Q000627:therapeutic use; D051379:Mice; D044925:Oxidoreductases Acting on CH-CH Group Donors / Q000172:deficiency* / Q000235:genetics*; D019082:Smith-Lemli-Opitz Syndrome / Q000201:enzymology / Q000628:therapy
D002784:Cholesterol; D044925:Oxidoreductases Acting on CH-CH Group Donors; C019995:7-dehydrocholesterol reductase
Am J Med Genet. 2001 Jul 22;102(1):18-20
11471166
Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2065-9
1848692
Am J Med Genet. 2000 Jan 31;90(3):260
10678669
Prenat Diagn. 2001 Mar;21(3):207-12
11260610
Mol Genet Metab. 2005 Feb;84(2):112-26
15670717
J Virol. 2004 Mar;78(6):3110-22
14990730
Curr Opin Lipidol. 2001 Apr;12(2):105-12
11264981
Curr Opin Pediatr. 1999 Aug;11(4):353-62
10439210
Prenat Diagn. 2006 Sep;26(9):842-9
16832833
Steroids. 2007 Oct;72(11-12):802-8
17714750
Gene Ther. 1999 Jun;6(6):973-85
10455399
J Med Genet. 1998 Jul;35(7):558-65
9678700
Curr Opin Pediatr. 2003 Dec;15(6):607-13
14631207
Mol Ther. 2002 May;5(5 Pt 1):617-26
11991753
Hum Mol Genet. 2001 Mar 15;10(6):555-64
11230174
Gene Ther. 1998 Jul;5(7):938-45
9813665
Am J Med Genet. 2001 Jan 15;98(2):191-200
11223857
Mol Genet Metab. 2001 Jan;72(1):67-71
11161831
Am J Med Genet. 1999 Feb 19;82(5):376-81
10069707
Am J Med Genet A. 2007 Sep 15;143A(18):2129-36
17702049
Eur J Pediatr. 2010 Jan;169(1):121-3
19365639
Pediatr Res. 2009 Jun;65(6):681-5
19430384
Am J Med Genet. 1980;5(2):137-43
7395908
Hum Mol Genet. 2006 Mar 15;15(6):839-51
16446309
Am J Med Genet. 1995 Apr 10;56(3):281-5
7778590
Gene Ther. 2006 Jun;13(11):917-25
16482204
Eur J Med Genet. 2006 Nov-Dec;49(6):499-504
16497572
Clin Chim Acta. 1995 Apr 30;236(1):45-58
7664465
Annu Rev Genomics Hum Genet. 2001;2:299-341
11701653
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8181-6
9653161
Am J Med Genet. 1997 Jan 31;68(3):311-4
9024565
Clin Chem. 2008 Aug;54(8):1317-24
18556335
Am J Med Genet. 1997 Jan 31;68(3):305-10
9024564
Am J Med Genet A. 2010 Jan;152A(1):91-5
20014133
Gene Ther. 1998 Dec;5(12):1642-9
10023443
Gene Ther. 2001 Sep;8(17):1291-8
11571565
Am J Med Genet. 2001 Sep 1;102(4):383-6
11503168
J Pediatr. 2004 Jun;144(6):783-91
15192627
Am J Med Genet A. 2006 Oct 1;140(19):2057-62
16906538
J Med Genet. 2000 May;37(5):321-35
10807690
J Inherit Metab Dis. 2007 Jun;30(3):375-87
17497248